135 related articles for article (PubMed ID: 32064285)
1. A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques.
Ayubcha C; Hosoya H; Mehdizadeh Seraj S; Zirakchian Zadeh M; M S E TW; Alavi A
Asia Ocean J Nucl Med Biol; 2020; 8(1):64-68. PubMed ID: 32064285
[TBL] [Abstract][Full Text] [Related]
2. The role of
Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
[TBL] [Abstract][Full Text] [Related]
3. Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [
Bastian MB; Blickle A; Burgard C; Fleser O; Christofyllakis K; Ezziddin S; Rosar F
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786281
[TBL] [Abstract][Full Text] [Related]
4. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
8. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
9. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies.
Weinberg RS; Worsley A; Gilbert HS; Cuttner J; Berk PD; Alter BP
Leuk Res; 1989; 13(4):331-8. PubMed ID: 2716348
[TBL] [Abstract][Full Text] [Related]
10. Serum chitotriosidase: a circulating biomarker in polycythemia vera.
Krecak I; Gveric-Krecak V; Roncevic P; Basic-Kinda S; Gulin J; Lapic I; Fumic K; Ilic I; Horvat I; Zadro R; Holik H; Coha B; Peran N; Aurer I; Durakovic N
Hematology; 2018 Dec; 23(10):793-802. PubMed ID: 29993340
[TBL] [Abstract][Full Text] [Related]
11. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
12. The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.
Slot S; van de Donk NWCJ; Otten RHJ; Boden BJH; Zijlstra J; Raijmakers PGHM; Zweegman S
Cancer Imaging; 2021 Apr; 21(1):36. PubMed ID: 33879266
[TBL] [Abstract][Full Text] [Related]
13. Outcomes Following Posterior Lumbar Fusion in Patients with Polycythemia Vera.
Labaran LA; Vatani J; Bell J; Puvanesarajah V; Sequeira S; Raad M; Jain A; Hassanzadeh H
World Neurosurg; 2020 Feb; 134():e372-e378. PubMed ID: 31639499
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
15. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia Vera.
Spivak JL
Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
[TBL] [Abstract][Full Text] [Related]
17. Polycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant.
Erdinc B; Ramachandran P; Boris A
Cureus; 2020 Jun; 12(6):e8404. PubMed ID: 32637283
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
19. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
Jakovic L; Gotic M; Gisslinger H; Soldatovic I; Sefer D; Tirnanic M; Lekovic D; Jovanovic MP; Schalling M; Gisslinger B; Beham-Schmid C; Simonitsch-Klupp I; Thiele J
Ann Hematol; 2018 Sep; 97(9):1581-1590. PubMed ID: 29717365
[TBL] [Abstract][Full Text] [Related]
20.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
